Financial News
Articles published by Amneal Pharmaceuticals, Inc.


Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA
March 03, 2025
Via Business Wire
Tickers
AMRX

Amneal Reports Fourth Quarter and Full Year 2024 Financial Results
February 28, 2025
Via Business Wire
Tickers
AMRX

Via Business Wire
Tickers
AMRX

Via Business Wire
Tickers
AMRX


Amneal to Participate at Upcoming Investor Conferences
December 04, 2024
Via Business Wire
Tickers
AMRX


Amneal Reports Third Quarter 2024 Financial Results
November 08, 2024
Via Business Wire
Tickers
AMRX


Amneal to Report Third Quarter 2024 Results on November 8, 2024
October 08, 2024
Via Business Wire
Tickers
AMRX




Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials
August 20, 2024
Via Business Wire
Tickers
AMRX



Via Business Wire
Tickers
AMRX

Via Business Wire
Tickers
AMRX

Via Business Wire
Tickers
AMRX


Via Business Wire
Tickers
AMRX



Via Business Wire
Tickers
AMRX




Amneal to Report First Quarter 2024 Results on May 3, 2024
April 10, 2024
Via Business Wire
Tickers
AMRX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.